STAGE 0A BLADDER CANCER AJCC V8
Clinical trials for STAGE 0A BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE 0A BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE 0A BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough bladder cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to the chemotherapy drug gemcitabine can help people with a type of bladder cancer that didn't get better with standard BCG treatment. About 161 adults with non-muscle invasive bladder cancer will receive both d…
Matched conditions: STAGE 0A BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Bladder cancer survivors: how does treatment change your daily life?
Knowledge-focused OngoingThis study follows 204 people with bladder cancer to see how their treatment (surgery or radiation) affects their quality of life. Participants fill out surveys about physical function, pain, fatigue, mood, and bladder, bowel, and sexual health. The goal is to understand the real…
Matched conditions: STAGE 0A BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 04:01 UTC